Expanding the genetic and clinical characteristics of Protocadherin 19 gene mutations
Giovanni Battista Dell’Isola(Saint Camillus International University of Health and Medical Sciences), Alberto Verrotti(University of Perugia), Elisabetta Mencaroni(University of Perugia), Giorgia Tascini(University of Perugia), Valentina Imperatore(Ospedale Santa Maria), Antonella Fattorusso(University of Perugia), Paolo Prontera(Ospedale Santa Maria), Pasquale Striano(Istituto Giannina Gaslini), Giuseppe Di Cara(University of Perugia)
Cited by 8
Related Papers
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Autism Spectrum Disorders and the Gut Microbiota
|Nutrients|2019|479
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
|Frontiers in Neurology|2021|260
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
|Nature Communications|2019|248
Defining the phenotypic spectrum of <i>SLC6A1</i> mutations
|Epilepsia|2018|151